TUCSON, Ariz., Oct. 25, 2018 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics, Inc. HTGM, a provider of instruments, reagents and services for molecular profiling applications, today announced that it will report its financial results for the three and nine months ended September 30, 2018 after the market close on Thursday, November 8. Management will also host a conference call with investors to discuss financial results and provide a corporate update at 4:30pm Eastern Time.
Conference Call & Webcast Details
Date:Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Thursday, November 8
Time:Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â 4:30pm Eastern Time
Toll Free:Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â 800-458-4121
International:Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â 323-794-2093
Conference ID:Â Â Â Â Â Â Â Â Â Â Â Â Â 5881694
Webcast:Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â http://public.viavid.com/index.php?id=131460
About HTG:
HTG is focused on next generation sequencing (NGS) based molecular profiling. The company's proprietary HTGÂ EdgeSeq technology automates complex, highly multiplexed molecular profiling from solid and liquid samples, even when limited in amount. HTG's customers use its technology to identify biomarkers important for precision medicine, to understand the clinical relevance of these discoveries, and ultimately to identify treatment options. Our mission is to empower precision medicine at the local level.
Contact:
Ashley R. Robinson
LifeSci Advisors, LLC
Phone: (617) 525-7754
Email: arr@lifesciadvisors.com
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
